Chest
-
Respiratory Support PostersSESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: COPD is a major cause of morbidity and mortality worldwide, representing a major public health problem due to the high health and economic resource consumption. Pulmonary rehabilitation is a standard care recommendation for these patients, in order to control the symptoms and optimize the functional capacity, reducing healthcare costs associated with exacerbations and activity limitations and participation. However, in patients with severe COPD exercise performance can be difficult, due to extreme dyspnea, decreased muscle strength and fatigue. In addition, hypoxemia and dyspnea during efforts and daily activities may occur, limiting their quality of life. Thus, NIV have been used as adjunct to exercise, in order to improve exercise capacity in these patients. However, there is no consensus for this technique recommendation. Our objective was to verify whether the use of NIV during exercise is effective than exercise without NIV in dyspnea, walked distance, blood gases and health status in COPD patients, through a systematic review and meta-analysis. ⋯ Sara Correia: Employee: salary The following authors have nothing to disclose: Teresa Tomás, Elisabete CarolinoNo Product/Research Disclosure Information.
-
Critical Care Case Report PostersSESSION TYPE: Case Report PosterPRESENTED ON: Sunday, March 23, 2014 at 01:15 PM - 02:15 PMINTRODUCTION: First described in 1950, cerebral salt wasting syndrome (CSW) is defined by development of extracellular volume depletion due to renal sodium transport abnormality in patients with intracranial disease and normal adrenal and thyroid function [1]. The entity has been controversial and its existence debatable. ⋯ This case illustrates the need for CSW recognition as a separate entity from SIADH. Failure to make this distinction in a patient with hyponatremia who has cranial conditions could lead to unbefitting and dangerous therapy with water restriction resulting in fatal outcomes.Reference #1: Peters JP, et al. A salt-wasting syndrome associated with cerebral disease. Trans Assc Am Phys. 1950, 63:57-64Reference #2: Schwartz WB, et al. A syndrome of renal sodium loss and hyponatremia probably resulting from inappropriate secretion of antidiuretic hormone. Am J Med 1957 Oct 23(4):529-42DISCLOSURE: The following authors have nothing to disclose: Anita Rajagopal, John LuciaNo Product/Research Disclosure Information.
-
Critical CareSESSION TYPE: Slide PresentationPRESENTED ON: Saturday, March 22, 2014 at 04:15 PM - 05:15 PMPURPOSE: This QI intervention is aimed at reducing delirium,increasing implementation of goal directed sedation and improving patient's functional status by early physical therapy (PT) in CCU. Based on current data, this can effectively decrease delirium and neuromuscular deconditioning in intensive care patients. Our goals are to: 1) Increase delirium recognition by consistent implementation of Confusion Assessment Measurement (CAM-ICU), 2) reduce deep sedation by goal directed sedation protocols, 3)improve patients' functional mobility by increasing the number and earlier timing of PT treatments. ⋯ The following authors have nothing to disclose: Jasleen Pannu, Sarah Lee, Dereddi Raja Reddy, Pramod Guru, Mazen Al-Qadi, Bernardo SelimNo Product/Research Disclosure Information.
-
Pulmonary Hypertension Posters IISESSION TYPE: Poster PresentationsPRESENTED ON: Saturday, March 22, 2014 at 01:15 PM - 02:15 PMPURPOSE: To outline the resource use and costs a U.S. health plan can anticipate during the evaluation and first year of treatment of a PAH patient. ⋯ Vijay Joish: Employee: employee of bayer sponsor of the study Christine Divers: Employee: Employee of Bayer Chakkarin CBurudpakdee: Consultant fee, speaker bureau, advisory committee, etc.: paid consultant of Bayer Anshul Shah: Consultant fee, speaker bureau, advisory committee, etc.: paid consultant of Bayer Stephen Mathai: Consultant fee, speaker bureau, advisory committee, etc.: Paid consultant of Bayer, sponsor of this studyNo Product/Research Disclosure Information.
-
Slide PresentationPRESENTED ON: Monday, March 24, 2014 at 10:45 AM - 11:45 AMPURPOSE: Recently, the CAT is recommended as a promising tool for assessing the impact of COPD on the indivudual patient. Although it was known that COPD patients have a high frequency of comorbidities, little known about the contribution of these comorbidities to CAT score. We aimed to assess the impact of comorbidities on disease specific health status as assessed by CAT in patients with stable COPD. ⋯ The following authors have nothing to disclose: Sibel Atis Nayci, Eylem Sercan Özgür, Cengiz Özge, Yasin Duman, Ahmet IlvanNo Product/Research Disclosure Information.